K233895

EZ Glide Aortic Perfusion Cannulae (EZC21A, EZC21TA, EZC24A, EZC24TA, EZF21A, EZF21TA, EZF24A, EZF24TA, EZS21A, EZS21TA, EZS24A and EZS24TA); OptiSite Arterial Perfusion Cannulae (OPTI16, OPTI18, OPTI20 and OPTI22); EndoReturn Arterial Cannulae (ER21B and ER23B);

510(k) 号: K233895
器械名称: EZ Glide Aortic Perfusion Cannulae (EZC21A, EZC21TA, EZC24A, EZC24TA, EZF21A, EZF21TA, EZF24A, EZF24TA, EZS21A, EZS21TA, EZS24A and EZS24TA); OptiSite Arterial Perfusion Cannulae (OPTI16, OPTI18, OPTI20 and OPTI22); EndoReturn Arterial Cannulae (ER21B and ER23B);
申请人: Edwards Lifesciences CA · US
产品代码: DWF — Catheter, Cannula And Tubing, Vascular, Cardiopulmon
批准日期: 2024-02-05
受理日期: 2023-12-11
决定: Substantially Equivalent
审查途径: Special
咨询委员会: Cardiovascular

510(k) Summary（FDA 官方 PDF）： K233895.pdf

FDA 官方记录： K233895

数据来自 openFDA 510(k) 数据集（CC0 公有领域），以 FDA 现行记录为准。510(k) 许可不等于 FDA 认证或批准。